Cleared Traditional

K151715 - T3 Software

K151715 is an FDA 510(k) clearance for T3 Software, manufactured by Etiometry, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 126-day FDA review.

K151715 · Etiometry, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2015
Decision
126d
Days
Class 2
Risk

K151715 is an FDA 510(k) clearance for the T3 Software. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Etiometry, Inc. (Boston, US). The FDA issued a Cleared decision on October 29, 2015 after a review of 126 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Etiometry, Inc. devices

FDA 510(k) Submission Details - K151715

510(k) Number K151715 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 2015
Decision Date October 29, 2015
Days to Decision 126 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d slower than avg
Panel avg: 125d · This submission: 126d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Quintiles
RICHARD E GALGON

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 295
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K151715.
Expression MR400 MRI Patient Monitoring System
K152330 · Invivo Corporation · Dec 2015
ViSi Mobile Monitoring System
K152341 · Sotera Wireless, Inc. · Dec 2015
Checkme Pro Health Monitor
K150869 · Viatom Technology Co., Ltd. · Dec 2015
Tempus IC2
K152124 · Remote Diagnostics Technologies, Ltd. · Oct 2015
SmartLinx Vitals Plus Patient Monitoring System
K151071 · Capsule Technologie Sas · Sep 2015
STAR 90
K150512 · Skanray Technologies Pvt, Ltd. · Jun 2015